The SeriousTraders Newsletter If you are Serious about Trading, become a SeriousTrader!™

Soligenix Inc. (NASDAQ: SNGX)

Investment Considerations Soligenix has multiple late-stage assets with orphan and fast-track designations, providing a clear regulatory pathway toward potential approvals. The company’s pipeline has a total addressable market exceeding $2 billion, spanning rare diseases, inflammation, and biothreat applications. Soligenix has benefited from significant non-dilutive government funding, which reduces operational expenses and financial risk while supporting … Continue reading “Soligenix Inc. (NASDAQ: SNGX)”

View Profile